Healthcare -
Biotechnology - NASDAQ - US
$ 70.925
-0.33 %
$ 13.5 B
Market Cap
32.09
P/E
BMRN - STOCK-BASED COMPENSATION
Stock-based Compensation BMRN - BioMarin Pharmaceutical Inc.
202 M
LAST VALUE
1.33%
2 YEAR CAGR
4.75%
5 YEAR CAGR
8.61%
10 YEAR CAGR